Metin Tascilar
Metin Tascilar publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Pancreatic and Hepatic Oncology Research, Prostate Cancer Treatment and Research and Renal cell carcinoma treatment.
- World rank
- #1,603,074 of 7,710,434 ranked researchers
- Rank in Netherlands
- #35,816 of 107,149
- Works
- 51
- Citations
- 3.6k
- Citations per work
- 71.5
What does Metin Tascilar research?
Metin Tascilar's work is mostly in Medicine (69%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3569.2%
- Medicine3569.2%
- Everything else917.8%
- Life Sciences713.0%
- 1Pulmonary and Respiratory Medicine23% of their works
- 2Oncology23% of their works
- 3Surgery19% of their works
- 4Molecular Biology8% of their works
- 5Cancer Research6% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Genomics and Diagnostics
- Prostate Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Pancreatitis Pathology and Treatment
Which keywords describe Metin Tascilar's research?
The keywords of their largest research topics: Immunotherapy, Genetic Mutations, Chemotherapy, Neoadjuvant Therapy, Prostate Cancer, Prognostic Factors, Pancreatic Cancer and Surgical Complications.
- Screening
- Chronic Pancreatitis
- Acute Pancreatitis
- Cancer Genomics
- Metastatic
- Biliary Tract Cancer
- Genomic Profiling
- Clinical Guidelines
- Surgical Complications
- Prognostic Factors
- Neoadjuvant Therapy
- Genetic Mutations
- Immunotherapy
- Chemotherapy
- Prostate Cancer
- Pancreatic Cancer
- Androgen Receptor
- Epidemiology
- Molecular Characterization
- Cholangiocarcinoma
- Renal Cell Carcinoma
- Mutational Signatures
- Bladder Cancer
- Radiation Therapy
- Urothelial Carcinoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Immunotherapy414 topics
- Genetic Mutations212 topics
- Chemotherapy202 topics
- Neoadjuvant Therapy202 topics
- Prostate Cancer182 topics
- Prognostic Factors162 topics
- Pancreatic Cancer151 topic
- Surgical Complications151 topic
- Androgen Receptor131 topic
- Clinical Guidelines132 topics
- Epidemiology132 topics
- Genomic Profiling131 topic
- Molecular Characterization132 topics
- Biliary Tract Cancer81 topic
- Cholangiocarcinoma81 topic
- Metastatic81 topic
- Renal Cell Carcinoma81 topic
- Cancer Genomics61 topic
- Mutational Signatures61 topic
- Acute Pancreatitis51 topic
- Bladder Cancer51 topic
- Chronic Pancreatitis51 topic
- Radiation Therapy51 topic
- Screening51 topic
- Urothelial Carcinoma51 topic
Where does Metin Tascilar work?
Metin Tascilar's main affiliation in the publication record is Isala, Netherlands.
How many publications and citations does Metin Tascilar have?
OpenAlex counts 51 works and 3,648 citations for Metin Tascilar, an h-index of 20, ranking #1,603,074 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Metin Tascilar. Posts are plain text and can be reported.